Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BSI-04702 by OBI Pharma for Non-Small Cell Lung Cancer: Likelihood of Approval
BSI-04702 is under clinical development by OBI Pharma and currently in Phase II for Non-Small Cell Lung Cancer. According to...
BSI-04702 by OBI Pharma for Solid Tumor: Likelihood of Approval
BSI-04702 is under clinical development by OBI Pharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
BSI-04702 by OBI Pharma for Small-Cell Lung Cancer: Likelihood of Approval
BSI-04702 is under clinical development by OBI Pharma and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...
BSI-04702 by OBI Pharma for Gastric Cancer: Likelihood of Approval
BSI-04702 is under clinical development by OBI Pharma and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...